Clinlogix acquires ikfe CRO

16 October 2013

Clinical research organization Clinlogix has expanded operations in Europe with the acquisition of Mainz-based ikfe CRO GmbH.

Dr Marco Grenningloh PhD, Chief Operating Officer and Managing Director of Clinlogix Europe, said, "This acquisition greatly strengthens our strategic resources, knowledge base and infrastructure in the largest pharmaceutical market in the world. ikfe CRO was a highly respected regional service provider, and their specialized expertise and in-depth understanding are further enhancing our ability to provide knowledgeable, high quality services to our clients around the globe."

From its base in Germany, Clinlogix Europe is a full service organization that supports the development of drugs, devices and diagnostics throughout Europe. It works in a variety of therapeutic areas but has special expertise in diabetes, cardiovascular disease and oncology.

	Clinlogix acquires ikfe CRO 16 October 2013 Your browser does not support inline frames or is currently configured not to display inline frames. Clinical research organization Clinlogix has expanded operations in Europe with the acquisition of Mainz-based ikfe CRO GmbH. Dr Marco Grenningloh PhD, Chief Operating Officer and Managing Director of Clinlogix Europe, said, "This acquisition greatly strengthens our strategic resources, knowledge base and infrastructure in the largest pharmaceutical market in the world. ikfe CRO was a highly respected regional service provider, and their specialized expertise and in-depth understanding are further enhancing our ability to provide knowledgeable, high quality services to our clients around the globe." From its base in Germany, Clinlogix Europe is a full service organization that supports the development of drugs, devices and diagnostics throughout Europe. It works in a variety of therapeutic areas but has special expertise in diabetes, cardiovascular disease and oncology. To top